bacillu
pumilu
ribonucleas
binas
shown
promis
antivir
agent
anim
model
cell
cultur
howev
mode
antivir
action
remain
unknown
assess
binas
effect
intracellular
viral
rna
select
singl
strand
negativeand
positivesens
rna
virus
influenza
viru
rhinoviru
respect
annual
caus
respiratori
ill
character
high
contagi
natur
mutat
rate
antigen
variabl
shown
binas
exert
antivir
effect
virus
concentr
alter
spectrum
cellular
protein
express
housekeep
gene
titer
influenza
viru
human
rhinoviru
serotyp
reduc
respect
preincub
influenza
viru
binas
infect
significantli
reduc
viral
titer
singlecycl
replic
viru
use
influenza
viru
mini
genom
system
show
binas
reduc
gfp
report
signal
indic
binas
action
express
viral
mrna
binas
reduc
level
viral
np
mrna
accumul
cell
sinc
viral
mrna
possibl
target
binas
agent
could
potenti
appli
antivir
therapi
negativeand
positivesens
rna
virus
singl
strand
rna
virus
negativesens
ebola
marburg
lassa
influenza
positivesens
human
immunodefici
virus
import
human
pathogen
world
recent
viru
outbreak
larg
number
human
death
caus
rna
virus
like
ebola
corona
zika
differ
strain
influenza
virus
among
rna
virus
respiratori
virus
highli
contagi
caus
annual
worldwid
epidem
occasion
pandem
outbreak
influenza
viru
even
without
pandem
outbreak
kill
half
million
human
year
great
number
diseas
attribut
human
rhinovirus
hrv
major
caus
common
cold
hrv
infect
suffer
everyon
recent
report
suggest
hrv
infect
associ
sever
respiratori
ill
children
main
problem
antivir
therapi
drug
resist
although
major
common
viral
diseas
selflimit
ill
requir
specif
antivir
therapi
antivir
drug
help
prevent
complic
shorten
sever
durat
viral
diseas
symptom
consider
econom
loss
annual
epidem
promot
constant
search
new
antivir
agent
becom
useless
time
due
high
variabl
virus
usual
two
group
drug
use
treatment
influenza
first
group
includ
rimantadin
analog
inhibit
ion
channel
function
protein
biom
research
intern
therebi
inhibit
viral
uncoat
second
one
repres
oseltamivir
inhibit
enzym
neuraminidas
induc
adapt
immun
vaccin
inactiv
attenu
antigen
materi
virus
help
prevent
influenza
ill
reduc
impact
individu
perman
vaccin
influenza
viru
year
countri
lose
larg
amount
money
budget
prepar
new
vaccin
rescu
nation
public
health
life
widespread
antivir
resist
due
high
mutat
rate
viral
genom
limit
clinic
impact
type
medicin
product
prevent
treatment
influenza
infect
current
vaccin
hrv
hrv
almost
highest
number
serotyp
among
respiratori
virus
due
mutat
genom
antigen
heterogen
hrv
regard
major
barrier
effect
vaccin
develop
highli
polyval
result
littl
progress
year
problem
imped
rhinovir
vaccin
develop
includ
lack
conveni
anim
model
expect
absenc
great
impact
respiratori
morbid
mortal
reduc
frequenc
common
cold
today
drug
destroy
virus
antivir
agent
inhibit
viral
develop
therefor
degrad
viral
rna
seem
promis
approach
antivir
therapi
earliest
studi
antivir
activ
rnase
perform
use
pancreat
rnase
agent
quickli
normal
state
decreas
symptom
mening
cerebrospin
pleocytosi
patient
tick
born
enceph
shortcom
mammalian
rnase
affin
cytosol
rnase
inhibitor
protein
ri
human
cell
adventiti
mammalian
rnase
inhibit
contrast
bacteri
rnase
inhibit
ri
retain
catalyt
activ
mammalian
tissu
one
wellstudi
bacteri
rnase
binas
guanylpref
low
molecular
weight
rnase
secret
bacillu
pumilu
propos
earlier
mechan
antivir
activ
rnase
includ
direct
action
nucleic
acid
indirect
effect
intervent
rna
interfer
immunomodul
induct
infect
cell
apoptosi
review
see
demonstr
binas
reduc
titer
pandem
influenza
reoviru
serotyp
reo
herp
viru
type
pseudorabi
middl
east
respiratori
syndrom
coronaviru
merscov
human
corona
viru
infect
madindarbi
canin
kidney
mdck
epitheli
cell
african
green
monkey
kidney
vero
cell
madindarbi
bovin
kidney
mdbk
epitheli
cell
human
fetal
lung
fibroblast
cell
hepatocellular
carcinoma
cell
respect
influenza
virus
contain
singl
strand
negativesens
rna
reovirus
doubl
strand
rna
genom
herp
viru
possess
genom
dna
specif
catalyt
activ
binas
toward
rna
mainli
singl
strand
inhibitori
effect
toward
rnaand
dnacontain
virus
could
propos
enzym
affect
mrna
synthes
virus
aim
studi
prove
viral
mrna
direct
target
binas
cell
virus
stock
human
lung
adenocarcinoma
epitheli
hela
human
cervic
cancer
mdckii
madindarbi
canin
kidney
epitheli
cell
cultur
growth
dulbecco
modifi
eagl
medium
dmem
gibco
usa
supplement
fetal
bovin
serum
paa
austria
uml
penicillin
mgml
streptomycin
ps
gibco
usa
incub
c
co
atmospher
pandem
influenza
human
rhinoviru
serotyp
provid
strain
collect
institut
medic
virolog
justu
liebig
univers
giessen
germani
propag
mdckii
hela
cell
respect
briefli
mdckii
hela
monolay
incub
multipl
infect
moi
dilut
pb
ba
pb
contain
bovin
albumin
paa
germani
mm
mgcl
mm
cacl
uml
penicillin
mgml
streptomycin
h
viru
adsorpt
dark
cell
monolay
supplement
medium
incub
either
c
c
humidifi
co
condit
isol
binas
ec
bacteri
extracellular
guanylpref
ribonucleas
collect
cultur
medium
bacillu
pumilu
former
name
b
intermediu
cultur
grown
l
conic
flask
contain
flask
volum
phosphat
defici
liquid
medium
low
phosphat
pepton
glucos
cacl
nacl
mgso
mnso
ph
rpm
multitron
shake
incub
infor
ht
switzerland
c
begin
stationari
phase
bacteri
growth
centrifug
min
pellet
bacteri
cell
remov
supernat
acidifi
glacial
acet
acid
ph
dilut
doubledistil
water
ddh
appli
column
cellulos
whatman
uk
equilibr
mm
sodium
acet
buffer
ph
flow
transfer
column
pack
phosphocellulos
whatman
uk
equilibr
mm
sodium
acet
buffer
ph
system
equilibr
mm
sodium
phosphat
buffer
ph
binas
elut
mm
sodium
phosphat
buffer
ph
polish
purif
binas
perform
use
uno
column
biolog
duoflow
chromatographi
system
biorad
usa
equilibr
mm
sodium
acet
buffer
ph
elut
use
linear
gradient
nacl
elut
fraction
ml
collect
protein
sampl
frozen
overnight
c
follow
freez
min
c
lyophil
h
c
vacuum
use
labconco
freezon
liter
freez
dri
system
labconco
usa
homogen
authent
purifi
enzym
confirm
paag
electrophoresi
western
blot
maldi
toftof
mass
spectrometri
ultraflextrem
bruker
corpor
germani
describ
ribonucleas
activ
binas
regist
nm
absorb
measur
product
binas
hydrolysi
high
molecular
weight
yeast
rna
binas
incub
trishcl
buffer
ph
presenc
g
l
rna
final
concentr
water
bath
min
c
reaction
stop
addit
ice
cold
perchlor
acid
follow
incub
ice
bath
min
follow
centrifug
min
supernat
dilut
ddh
use
nm
absorb
measur
use
spectrophotomet
smartspec
plu
biorad
usa
one
unit
ribonucleas
activ
correspond
quantiti
enzym
increas
extinct
acidsolubl
product
rna
hydrolysi
nm
optic
unit
incub
h
c
calcul
per
ml
enzym
solut
identifi
enzymat
activ
binas
growth
medium
subconflu
cell
plate
triplic
replac
gml
binas
final
concentr
contain
complet
dmem
incub
h
c
co
supernat
cell
cultur
fluid
contain
binas
collect
measur
binas
activ
use
rnase
activ
assay
describ
see
section
cytotox
concentr
cc
concentr
compound
caus
death
viabl
cell
hela
cell
binas
treatment
measur
use
mtt
assay
describ
shah
mahmud
ilinskaya
briefli
growth
medium
subconflu
hela
cell
plate
triplic
replac
dmem
contain
differ
concentr
binas
final
concentr
gml
kept
h
c
humidifi
co
incub
aspir
media
wash
pb
phosphatebuff
salin
contain
mm
mgcl
mm
cacl
cell
left
recov
min
growth
medium
replac
l
mttmix
growth
dmem
medium
contain
mgml
mttreagent
sigma
aldrich
usa
cell
incub
min
c
co
discard
mttmix
cell
fix
pfa
paraformaldehyd
roth
germani
min
rt
room
temperatur
fix
solut
discard
cell
air
dri
min
tetrazolium
crystal
dissolv
ad
l
isopropanol
well
plate
shaken
min
analyz
photometr
nm
excit
elisa
reader
biotek
usa
mtt
valu
binas
nontreat
control
use
percentag
cell
viabil
binas
exposur
calcul
follow
percentag
viabil
mtt
valu
control
mtt
valu
binasetr
sampl
cc
determin
use
graphpad
prism
softwar
graphpad
softwar
inc
usa
plot
percentag
viabl
cell
function
compound
concentr
determin
effect
gml
binas
viru
monolay
subcultur
prepar
plate
cellswel
follow
overnight
confluenc
monolay
growth
medium
remov
cell
monolay
wash
pb
viru
suspens
contain
moi
dilut
pb
ba
l
ad
well
incub
h
rt
viral
supernat
remov
binas
final
concentr
gml
infect
medium
dmem
contain
u
ml
penicillin
gml
streptomycin
bsa
paa
germani
gml
tpcktreat
trypsin
ad
cell
incub
h
viral
load
collect
supernat
estim
use
focu
assay
describ
cell
monolay
subject
cellular
total
protein
rna
extract
investig
binas
viru
preincub
min
infect
incub
step
perform
previous
describ
shah
mahmud
ilinskaya
effect
concentr
ec
concentr
compound
reduc
viru
titer
binas
determin
hela
cell
cell
grown
plate
triplic
overnight
c
co
cell
monolay
wash
infect
l
viru
suspens
pb
ba
moi
h
c
remov
viru
inoculum
cell
incub
l
growth
medium
well
contain
differ
concentr
binas
final
concentr
gml
h
c
co
supernat
contain
viru
assay
viral
titer
use
plaqu
assay
titrat
titer
determin
cell
cultur
plate
contain
subconflu
hela
cell
monolay
use
plaqu
assay
briefli
viru
inoculum
dilut
pb
ba
growth
media
hela
cell
remov
cell
monolay
wash
use
pb
dilut
viru
ad
well
incub
h
c
co
remov
l
avicelmedia
contain
mem
avicel
fmc
biopolym
belgium
ad
cell
incub
h
c
co
remov
overlay
media
cell
monolay
wash
pb
stain
crystal
violet
solut
wash
dri
plaqu
correspond
propag
viral
particl
count
titer
determin
mdckii
use
focu
assay
analyz
binas
effect
identifi
ec
binas
plaqu
count
pfuml
measur
use
ms
excel
softwar
packag
pfuml
valu
binas
nontreat
infect
hela
cell
use
ec
determin
use
graphpad
prism
softwar
graphpad
softwar
inc
usa
plot
percentag
viabl
cell
function
compound
concentr
perform
twodimension
differ
gel
electrophoresi
dige
protein
express
analysi
total
cellular
protein
binasetr
cell
gml
extract
h
incub
plate
triplic
binas
nontreat
cell
taken
control
remov
cell
cultur
media
cell
monolay
wash
twice
pb
scratch
collect
ml
pb
cell
pellet
centrifug
sec
c
supernat
discard
cell
pellet
lyse
ice
use
lysi
buffer
tlb
mm
tri
ph
mm
nacl
glycerol
sodium
dodecyl
sulphat
sodium
deoxychol
mm
edta
ph
mm
pefablock
gml
aprotinin
gml
leupeptin
mm
navanad
mm
benzamidin
ad
lysi
buffer
cell
incub
min
ice
success
centrifug
min
c
supernat
collect
protein
concentr
sampl
determin
accord
manufactur
instruct
use
bradford
assay
kit
biorad
usa
total
cellular
protein
g
binas
nontreat
control
binasetr
sampl
label
green
red
cyanin
dye
concentr
pmol
l
protein
respect
dye
protein
mix
incub
ice
h
dark
rt
label
reaction
termin
incub
mm
lysin
min
label
protein
mix
use
isoelectr
focus
ief
differ
gel
electrophoresi
isoelectr
ph
gradient
ipg
tube
gel
prepar
use
urea
acrylamid
ampholyt
chap
accord
protean
ief
cell
biorad
usa
manufactur
instruct
g
label
protein
mix
control
test
sampl
combin
l
standard
buffer
urea
chap
mm
trishcl
ph
contain
dtt
dithiothreitol
ad
onto
prepar
ief
gel
tube
firstdimension
isoelectr
focus
carri
protean
ii
xi
cell
biorad
usa
chamber
rt
use
follow
program
v
h
v
h
gradient
v
h
v
h
v
h
v
h
polyacrylamid
gradient
gel
twodimension
gel
electrophoresi
prepar
accord
protean
ief
cell
biorad
usa
manufactur
protocol
min
h
h
protein
separ
gel
cover
kda
rang
typhoon
fla
imag
ge
healthcar
uk
use
visual
protein
spot
gel
excit
emiss
wavelength
combin
nm
nm
use
captur
imag
protein
label
respect
spot
detect
match
carri
use
imagequ
tl
softwar
ge
healthcar
uk
identifi
binas
action
cellular
viral
mrna
express
level
cell
binasetreatedinfect
binasetreatednoninfect
noninfect
nontreat
cell
kept
h
plate
triplic
wash
pb
scratch
cell
collect
pb
immedi
count
cell
sampl
use
rna
extract
cdna
prepar
cell
sampl
lyse
rlt
buffer
qiagen
germani
total
rna
purifi
use
rneasi
mini
kit
qiagen
germani
accord
recommend
protocol
total
rna
sampl
elut
filter
use
volum
elut
buffer
equal
volum
total
rna
use
amplifi
cellular
mrna
actb
mrna
gapdh
viral
np
mrna
gene
cdna
use
mmlv
rt
kit
evrogen
russia
brief
g
total
rna
equal
volum
elut
sampl
mix
specif
revers
primer
preincub
min
c
immedi
snapcool
ice
revers
transcript
perform
l
solut
contain
preprepar
rna
primer
mix
u
mmlv
revers
transcriptas
mm
dntp
mix
mm
dtt
buffer
mmlv
rt
kit
evrogen
russia
u
ribolock
rnase
inhibitor
thermo
fisher
scientif
usa
rtpcr
perform
min
c
cdna
sampl
dilut
use
rnase
free
water
thermo
fisher
scientif
usa
use
templat
realtim
pcr
realtim
pcr
quantifi
cellular
viral
mrna
cell
use
qpcrmixh
sybr
kit
evrogen
russia
l
cdna
ng
reaction
see
section
forward
revers
primer
qpcrmixh
sybr
evrogen
russia
mix
lightcycl
multiwel
plate
roch
diagnost
switzerland
ice
dark
cover
lightcycl
seal
foil
thermal
cycl
done
lightcycl
roch
diagnost
switzerland
system
follow
condit
min
c
cycl
sec
c
sec
c
sec
c
quantif
data
analysi
perform
use
lightcycl
servic
softwar
roch
diagnost
switzerland
identif
binas
action
cellular
mrna
viral
np
mrna
accumul
accord
rel
folddiffer
express
level
rel
chang
gene
express
realtim
quantit
pcr
experi
use
intern
control
mrna
express
data
refer
gapdh
gene
use
correct
controlcalibr
binas
nontreat
testexperiment
binasetr
sampl
data
valu
calibr
influenza
virusinfect
binas
nontreat
cell
ct
target
ct
valu
obtain
use
viral
np
mrna
specif
primer
cell
refer
ct
valu
obtain
use
gapdh
mrna
primer
cell
valu
test
influenza
virusinfect
binasetr
cell
ct
target
ct
refer
calcul
fold
chang
calcul
use
valu
test
calibr
investig
effect
binas
gene
express
activ
viru
g
everi
five
plasmid
see
section
encod
viral
ribonucleoprotein
complex
togeth
ppoligfprt
cotransfect
cell
previous
describ
minor
modif
triplic
briefli
transfect
mixtur
consist
l
optimem
thermo
fisher
scientif
usa
total
g
plasmid
dna
along
l
miru
bio
usa
incub
min
rt
mixtur
dilut
ml
use
optimem
transfer
confluent
cell
monolay
grown
plate
allow
transfect
cell
kept
h
c
co
incub
transfect
medium
replac
ml
optimem
contain
ba
ps
binas
gml
without
binas
h
gfp
express
visual
count
axiovert
invert
fluoresc
microscop
zeiss
germani
statist
test
graphic
data
present
perform
use
graphpad
prism
softwar
graphpad
softwar
inc
usa
ms
excel
microsoft
usa
data
present
mean
standard
deviat
mean
sd
signific
two
group
determin
via
student
ttest
signific
differ
consid
valu
experi
involv
influenza
rhinoviru
serotyp
perform
use
biosafeti
level
contain
laboratori
approv
use
local
author
rp
giessen
germani
present
work
studi
effect
bacteri
ribonucleas
binas
infecti
titer
negativesens
singl
strand
rna
influenza
viru
singlecycl
replic
cell
cultur
h
pi
contradistinct
previou
report
maximum
antiinfluenza
effect
binas
multicycl
viru
replic
focus
time
period
h
pi
studi
viru
gene
express
moment
first
round
progeni
virion
format
found
min
preincub
binas
concentr
gml
viru
led
decreas
infecti
viru
titer
moi
figur
moi
reduct
viru
titer
binas
treatment
signific
higher
antivir
effect
binas
lower
viru
titer
suggest
possibl
administr
binas
earli
phase
viru
infect
prophylaxi
catalyt
activ
binas
gml
cell
cultur
media
decreas
h
incub
figur
b
correspond
data
obtain
earlier
gml
binas
binas
thermoand
phstabl
agent
use
vivo
retain
activ
reduct
binas
activ
cell
cultur
fluid
explain
intern
enzym
cell
binas
intern
cell
cytoplasm
nucleu
previous
illustr
immunofluoresc
method
possibl
inhibit
catalyt
activ
partial
degrad
binas
extracellular
proteas
exclud
though
thu
binas
act
antivir
agent
wide
rang
concentr
short
long
period
incub
moreov
addit
binas
administr
need
h
known
binas
concentr
gml
toxic
toward
cell
inhibit
viru
propag
shown
concentr
binas
gml
without
preincub
viru
moi
binas
reduc
infecti
titer
cell
cultur
singl
replic
round
figur
c
therefor
binas
seem
abl
act
intracellularli
virus
exit
cell
rais
question
regard
antivir
target
binas
virusinfect
cell
perform
binasetr
nontreat
cell
determin
binas
gml
alter
spectrum
cellular
protein
figur
moreov
express
cellular
housekeep
gene
measur
mrna
level
gene
encod
structur
protein
actb
metabol
protein
gapdh
chang
upon
treatment
cell
gml
binas
follow
h
incub
figur
b
time
binas
reduc
viral
np
mrna
accumul
cell
infect
viru
moi
figur
c
probabl
reflect
specif
reduct
viral
rna
express
gene
lower
binasetr
virusinfect
cell
virusinfect
binas
nontreat
cell
result
support
idea
inhibitori
effect
binas
viru
replic
figur
c
gain
detail
evid
binas
effect
viral
gene
express
cell
use
plasmid
base
revers
genet
system
contain
set
plasmid
encod
pa
np
gene
viral
rnp
complex
influenza
viruslik
rna
encod
gfp
report
protein
see
section
gfp
fluoresc
detect
plasmidencod
gene
rnp
complex
viruslik
rna
express
determin
binas
reduc
viral
rna
express
time
indic
binas
inhibit
express
viral
gene
figur
b
therefor
target
binas
antivir
action
could
viral
mrna
degrad
prevent
synthesi
viral
protein
figur
shown
scheme
reflect
differ
possibl
mechan
binas
effect
influenza
viral
function
ribonucleoprotein
rnp
complex
gene
express
use
vrnalik
encod
report
gene
gfp
step
step
start
intern
binas
step
b
step
block
viral
translat
step
c
step
depict
product
report
mrna
transcript
viral
rnp
mrna
inhibit
binas
base
conduct
experi
conclud
binas
act
synthes
positivesens
mrna
howev
rule
binas
would
digest
negativesens
vrna
viru
crna
respect
vrna
seem
less
possibl
vrna
protect
np
protein
moreov
degrad
would
result
complet
elimin
viru
cell
cultur
confirm
abil
binas
degrad
positivesens
rna
viru
ignor
intern
local
nuclei
order
serv
templat
translat
viral
protein
use
differ
system
hela
cell
infect
positivesens
rnacontain
viru
hela
cell
viru
easili
propag
replic
hela
cell
high
titer
show
binas
nontox
hela
cell
concentr
gml
figur
reduc
titer
viru
time
gml
figur
b
result
confirm
possibl
binas
degrad
viral
positivesens
rna
without
intern
nucleu
thu
regardless
negativeor
positivesens
genom
singl
strand
rna
virus
binas
might
abl
cleav
viral
rna
catalyt
therebi
inhibit
synthesi
viral
protein
properti
bacteri
enzym
uncov
promis
aspect
applic
new
antivir
agent
replic
success
virus
protect
genom
materi
degrad
host
cell
rna
virus
must
contend
numer
destabil
host
cell
process
includ
mrna
decay
pathway
viral
rna
degrad
result
antivir
respons
howev
virus
possess
specif
defens
system
bacteri
rnase
appli
exogen
viral
mrna
remain
import
target
antivir
drug
discoveri
impair
viral
rna
transcript
differ
strategi
use
exampl
sirna
duplex
direct
rift
valley
fever
viru
rvfv
nucleoprotein
effect
inhibit
rvfv
replic
human
cell
african
green
monkey
cell
vero
cell
shown
pretreat
cell
nucleoproteinspecif
sirna
markedli
reduc
viru
titer
proteinprotein
interact
subunit
play
pivot
role
assembl
function
polymeras
complex
essenti
replic
transcript
influenza
viru
rna
novel
small
molecul
compound
inhibit
interact
rnadepend
rna
polymeras
subunit
identifi
recent
effort
discoveri
antivir
drug
target
rna
provid
druglik
small
molecul
inhibit
viral
replic
includ
inhibitor
human
immunodefici
viru
hiv
hepat
c
viru
hcv
sever
acut
respiratori
syndrom
coronaviru
sar
cov
influenza
viru
highli
conserv
noncod
rna
ncrna
element
viral
genom
transcript
offer
new
opportun
expand
repertoir
drug
target
develop
antiinfect
therapi
virus
target
ncrna
compon
genom
transcript
may
promis
includ
insectborn
flavivirus
dengu
zika
west
nile
filovirus
ebola
marburg
accord
data
negativesens
positivesens
rnacontain
virus
target
binas
ssrna
transcript
influenza
viru
use
mrna
synthesi
structur
protein
ssrna
rhinoviru
use
mrna
packag
genom
rhinoviru
ssrna
need
transport
nucleu
influenza
ssrna
also
locat
cytoplasm
cytoplasm
alloc
ssrna
facilit
target
binas
shown
previous
nucleu
intern
transfect
massiv
intern
binas
nucleu
alreadi
start
h
binas
incub
cell
therefor
propos
binas
target
found
binas
nontox
concentr
eukaryot
cell
alter
cellular
protein
product
mrna
express
affect
viral
rna
product
binas
exert
antivir
effect
positiveand
negativesens
rna
virus
suggest
binas
promis
antivir
agent
differ
virus
rnase
ribonucleas
ri
rnase
inhibitor
protein
actb
actin
gapdh
dehydrogenas
rnp
ribonucleoprotein
gfp
green
fluoresc
protein
moi
multipl
infect
ffu
focu
form
unit
pi
postinfect
ief
isoelectr
focus
ssrna
positivesens
singl
strand
rna
negativesens
singl
strand
rna
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
